Deeptech startup Acculi Labs raises $1.5 Mn

Acculi Labs, a deep-tech life growth solution provider, has raised $1.5 million in a new investment round at a valuation of $25 million led by Sabi Holding India Ltd.

The Bengaluru-based company had earlier raised Rs 5 crore in a seed funding round led by PirE Ventures back in 2020.

The fresh fund will be utilized  to accelerate the development of its conscious AI insights systems, enhance its  manpower, operational efficiency, infrastructure development, Acculi Labs said in a press-release.

Co-founded in May 2017 by Rupam Das and Hari Prasath M, Acculi Labs aims to make home-based care available to the patients. The company’s flagship product, Lyfas, enables easy and regular early diagnostics and monitoring for early-stage asymptomatic patients  and helps them to approach their doctor at an early stage.

According to Acculi Labs, it expanded offerings from an initial cardiac health assessment system to a comprehensive suite of health solutions with the launch of Lyfas.The platform claims that its mobile application is capable of non-invasively capturing psychophysiological biomarkers and delivering a detailed health report within three minutes.

The company has developed Lyra, a cutting-edge, conscious AI that bridges the gap between carbon and silicon life forms. It has also launched Lyfas Udyam initiative, which provides a micro entrepreneurial circular economy for small entrepreneurs to start and run their businesses, leveraging the ecosystem, processes, and finance.